Microdeletion of the human CHRNA7 gene (α7 nicotinic acetylcholine receptor, nAChR) as well as dysfunction in N-methyl-D-aspartate receptors (NMDARs) have been associated with cortical dysfunction in a broad spectrum of neurodevelopmental and neuropsychiatric disorders including schizophrenia. However, the pathophysiological roles of synaptic vs. extrasynaptic NMDARs and their interactions with α7 nAChRs in cortical dysfunction remain largely uncharacterized. Using a combination of in vivo and in vitro models, we demonstrate that α7 nAChR gene deletion leads to specific loss of synaptic NMDARs and their coagonist, D-serine, as well as glutamatergic synaptic deficits in mouse cortex. α7 nAChR null mice had decreased cortical NMDAR expression and glutamatergic synapse formation during postnatal development. Similar reductions in NMDAR expression and glutamatergic synapse formation were revealed in cortical cultures lacking α7 nAChRs. Interestingly, synaptic, but not extrasynaptic, NMDAR currents were specifically diminished in cultured cortical pyramidal neurons as well as in acute prefrontal cortical slices of α7 nAChR null mice. Moreover, D-serine responsive synaptic NMDAR-mediated currents and levels of the D-serine synthetic enzyme serine racemase were both reduced in α7 nAChR null cortical pyramidal neurons. Our findings thus identify specific loss of synaptic NMDARs and their coagonist, D-serine, as well as glutamatergic synaptic deficits in α7 nAChR gene deletion models of cortical dysfunction, thereby implicating α7 nAChR-mediated control of synaptic NMDARs and serine racemase/D-serine pathways in cortical dysfunction underlying many neuropsychiatric and neurodevelopmental disorders, particularly those associated with deletion of human CHRNA7.
Introduction
As the major excitatory neurotransmitters in the CNS, the nicotinic and glutamatergic systems have been implicated in many neurological, neurodevelopmental and neuropsychiatric disorders (Dani and Bertrand, 2007; Traynelis et al., 2010; Waxman and Lynch, 2005) . Some of the most powerful evidence for the role of nicotinic receptors comes from genetic studies in which a homozygous microdeletion of human 15q13.3, including the α7 nAChR gene, is associated with disorders including schizophrenia, autism, mental retardation, epilepsy, and intellectual disability (Ancin et al., 2011; Endris et al., 2010; Helbig et al., 2009; Hoppman-Chaney et al., 2013; Lepichon et al., 2010; Liao et al., 2011; Miller et al., 2009; Sharp et al., 2008; Shinawi et al., 2009; Spielmann et al., 2011; Yasui et al., 2011) . Based on the size and the overlap of the deletions in different individuals, loss of the α7 nAChR gene alone appears sufficient to cause the majority of clinical features in such patients (Endris et al., 2010; Hoppman-Chaney et al., 2013; Liao et al., 2011; Shinawi et al., 2009 ). Deletion of the α7 nAChR gene in mice causes analogous abnormalities including impaired attention, working-memory and learning (Brown et al., 2010; Fernandes et al., 2006; Hellier et al., 2012; Levin et al., 2009; Young et al., 2007 Young et al., , 2011 .
Dysfunction in NMDARs has also been implicated in many neurological, neurodevelopmental and neuropsychiatric disorders including schizophrenia. In particular, NMDAR hypofunction has been suggested to underlie features of schizophrenia, and the NMDAR coagonist Dserine has been particularly implicated in models of this disorder. Targeted deletion or pathogenic perturbation of serine racemase (SR), which synthesizes D-serine in the brain, reduces D-serine production and glutamatergic transmission in the forebrain and leads to schizophrenia-like behavior in mice (Balu et al., 2013; Basu et al., 2009; Labrie et al., 2012; Ma et al., 2013) , suggesting that synaptic NMDAR hypofunction due to D-serine depletion may underlie functional glutamatergic deficits in schizophrenia. 
